Skip to content

NSAID Use in Postpartum Hypertensive Women

NSAID Use in Postpartum Hypertensive Women

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02902172
Enrollment
36
Registered
2016-09-15
Start date
2017-03-15
Completion date
2017-10-08
Last updated
2018-10-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Brief summary

Women who have the diagnosis of hypertension (pre-pregnancy and pregnancy induced) and deliver an infant via vaginal delivery will be placed into two groups in the postpartum period. One group will receive Ibuprofen for pain control and the other group will be given Tylenol. Blood pressures during the postpartum period will then be collected and compared in order to see if NSAIDs use increases blood pressure.

Detailed description

The patients who have a vaginal delivery and have the diagnosis of hypertension in pregnancy will be randomized to either Ibuprofen use or acetaminophen use during the postpartum period. Standard blood pressure monitoring in the postpartum period will be followed to help determine if there is a significant rise in the women who use NSAIDS in the postpartum period versus those that use acetaminophen. Groups will be divided into women with chronic hypertension, women with chronic hypertension with superimposed preeclampsia, women with preeclampsia without severe features, women with preeclampsia with severe features, women with gestational hypertension without severe range blood pressures, and women with gestational hypertension with severe range blood pressures. Recruitment will last 36 months. Patients will be monitored during their postpartum stay (typical 2 days) with blood pressure measurements. An additional 12 months will be needed for data analysis and publication.

Interventions

DRUGAcetaminophen

Blood pressure will be monitored during postpartum stay (typical 2 days) and then again at 1 week and 6 weeks (standard practice of care) with blood pressure measurements

DRUGNSAID

Blood pressure will be monitored during postpartum stay (typical 2 days) and then again at 1 week and 6 weeks (standard practice of care) with blood pressure measurements

Sponsors

St. Louis University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
14 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* vaginal delivery * diagnosis of chronic hypertension, chronic hypertension with superimposed preeclampsia * preeclampsia without severe features * preeclampsia with severe features gestational hypertension without severe range blood pressures * gestational hypertension with severe range blood pressures * singleton pregnancies

Exclusion criteria

* Cesarean Delivery * no diagnosis of hypertensive disorder * chronic or acute renal disease * allergy to ibuprofen or acetaminophen * lupus * multiple order pregnancies (twins, triplets) * Narcotic addiction/ in treatment for substance abuse/ current prescription drug user/ current use of illegal drugs

Design outcomes

Primary

MeasureTime frameDescription
Change in the Mean Systolic Blood Pressure From Postpartum Day 1 Versus Postpartum Day 2.2 daysTo determine if NSAIDS in the postpartum period raise blood pressure in women with a hypertensive disorder. The mean increase and standard deviation of each group (acetaminophen and NSAID/Ibupforen) was calculated when compairing systolic blood pressures from the first postpartum day to the second postpartum day. Day 1 is the mean of systolic blood pressures from 0 hours to 23 hours after delivery, and Day 2 is the mean of systolic blood pressures from 24 hours to 47 hours after delivery.

Secondary

MeasureTime frameDescription
Change in the Mean Diastolic Blood Pressure From Postpartum Day 1 Versus Postpartum Day 2.2 daysTo determine if NSAIDS in the postpartum period raise blood pressure in women with a hypertensive disorder. The mean increase and standard deviation of each group (acetaminophen and NSAID/Ibupforen) was calculated when compairing diastolic blood pressures from the first postpartum day to the second postpartum day. Day 1 is the mean of diastolic blood pressures from 0 hours to 23 hours after delivery, and Day 2 is the mean of diastolic blood pressures from 24 hours to 47 hours after delivery.

Countries

United States

Participant flow

Participants by arm

ArmCount
Acetaminophen
Women receiving acetaminophen for primary pain control following vaginal delivery.
16
NSAID
Women receiving Ibuprofen for primary pain control following vaginal delivery.
20
Total36

Baseline characteristics

CharacteristicAcetaminophenNSAIDTotal
Age, Continuous28 years25 years27 years
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
16 Participants20 Participants36 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Region of Enrollment
United States
16 Participants20 Participants36 Participants
Sex: Female, Male
Female
16 Participants20 Participants36 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 160 / 20
other
Total, other adverse events
0 / 160 / 20
serious
Total, serious adverse events
0 / 160 / 20

Outcome results

Primary

Change in the Mean Systolic Blood Pressure From Postpartum Day 1 Versus Postpartum Day 2.

To determine if NSAIDS in the postpartum period raise blood pressure in women with a hypertensive disorder. The mean increase and standard deviation of each group (acetaminophen and NSAID/Ibupforen) was calculated when compairing systolic blood pressures from the first postpartum day to the second postpartum day. Day 1 is the mean of systolic blood pressures from 0 hours to 23 hours after delivery, and Day 2 is the mean of systolic blood pressures from 24 hours to 47 hours after delivery.

Time frame: 2 days

Population: Mean difference day 1 compared to day 2 of systolic blood pressure

ArmMeasureValue (MEAN)Dispersion
AcetaminophenChange in the Mean Systolic Blood Pressure From Postpartum Day 1 Versus Postpartum Day 2.7.5 mmHgStandard Deviation 13.8
NSAIDChange in the Mean Systolic Blood Pressure From Postpartum Day 1 Versus Postpartum Day 2.5 mmHgStandard Deviation 6.1
p-value: <0.05Wilcoxon (Mann-Whitney)
Secondary

Change in the Mean Diastolic Blood Pressure From Postpartum Day 1 Versus Postpartum Day 2.

To determine if NSAIDS in the postpartum period raise blood pressure in women with a hypertensive disorder. The mean increase and standard deviation of each group (acetaminophen and NSAID/Ibupforen) was calculated when compairing diastolic blood pressures from the first postpartum day to the second postpartum day. Day 1 is the mean of diastolic blood pressures from 0 hours to 23 hours after delivery, and Day 2 is the mean of diastolic blood pressures from 24 hours to 47 hours after delivery.

Time frame: 2 days

ArmMeasureValue (MEAN)Dispersion
AcetaminophenChange in the Mean Diastolic Blood Pressure From Postpartum Day 1 Versus Postpartum Day 2.0.4 mmHgStandard Deviation 11.1
NSAIDChange in the Mean Diastolic Blood Pressure From Postpartum Day 1 Versus Postpartum Day 2.2.7 mmHgStandard Deviation 7.1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026